A double-antibody radioimmunoassay has been developed for the detection of Australia antigen and antibodies to Australia antigen in human sera. The assay is simple to perform, and can be completed in 18 hr. Based on parallel studies of human sera, it is approximately 2000 times more sensitive than agar gel diffusion and 200 times more sensitive than quantitative complement fixation. Australia antigen or antibody to Australia antigen was demonstrated in 22 of 23 single serum samples obtained from patients acutely ill with the longincubation form of hepatitis; eight of the sera were negative when evaluated by less sensitive techniques.
Since the Australia antigen (Au antigen) was first described in 1964 (1) , considerable evidence has accumulated to link it with viral hepatitis (2, 3) . This antigenic determinant (also called the hepatitis-associated antigen and the SH antigen) appears to reside on a virus-like particle about 200 A in diameter (4) . It has been observed most frequently in patients with the long-incubation form of viral hepatitis (2, 5) .
Current methods most frequently used in the testing for Au antigen are agar gel diffusion (2, 3), complement fixation (5, 6) , and various electrophoretic techniques (7, 8) . We have described a radioimmunoassay for the demonstration of Au antigen that uses human serum with antibodies to the Au antigen (anti-Au antibody) (9) . A more sensitive radioimmunoassay, using guinea pig serum that contains anti-Au antibody, has now been developed and is described in detail in this paper. The method is extremely sensitive, can be completed in less than 24 hr, and can be readily modified to test simultaneously for the presence of anti-Au antibodies.
MATERIAL AND METHODS Au antigen and anti-Au antibodies were initially demonstrated in human serum both by Ouchterlony agar gel diffusion and quantitative complement fixation (5) . Immunologic identity with the Au (1) antigen and anti-Au (1) antibody (2) was established by immunodiffusion with sera kindly supplied by Dr. Blumberg and his associates (Institute for Cancer Research, Fox Chase, Pa.). Au antigen was purified by column chromatography and density gradient ultracentrifugation. Serum was first placed on a column (2.5 X 100 cm) containing Sepharose 2-B, equilibrated with the eluent, 0.15 M NaCl in 0.05% Na deoxycholate. Au antigen was eluted well ahead of the major protein peak. Fractions containing Au antigen were pooled, dialyzed to remove detergent, and centrifuged (Spinco SW25.1 rotor at 25,000 rpm for 28 hr) in a preformed linear gradient of CsCl (density 1.09-1.30). After rebanding in a second CsCl gradient, of density 1.15-1.25, Au antigen was recovered in a single symmetrical peak (fraction density of about 1.20) of absorbance at 280 nm. 5 ml of serum, containing about 300 mg of protein, yielded about 50 ,ug (1.2 absorbance units at 280 nm) of protein (range 30-100 Mg, depending on the serum) by the Lowry technique (10); bovine serum albumin was used as the standard. The purified Au antigen preparation formed a single line of precipitation in agar gel diffusion with anti-Au antiserum. Human serum proteins were not detected by immunoelectrophoresis when tested against rabbit antiserum of high titer.
Anti-Au antibodies were prepared in guinea pigs by injections into the foot pad of about 25-100 ;&g of Au antigen, mixed in an equal volume of complete Freund's adjuvant. Animals were injected at about monthly intervals with [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Ag of Au antigen protein in Freund's adjuvant. Anti-guinea pig IgG and anti-human IgG antibodies, for use in the double radioimmunoassay procedure, were prepared in rabbits by immunization with the appropriate purified IgG (11) . The Au antigen preparation described above (or, more recently, material isolated by zonal centrifugation*) was radiolabeled by the Chloramine-T method of Hunter and Greenwood (12) . The reaction mixture contained Au antigen (about 0.004 absorbance unit at 280 nm), 1 For the detection of anti-Au antibodies in human sera, the samples were incubated with [125I]Au antigen for 1 hr at 370C, then an excess of rabbit anti-human IgG was added and the incubation was continued for another 15 hr at 40C.
86 serum samples, each from a different individual, were evaluated initially by agar gel diffusion and complement fixation. Study groups included: (a) 15 sera from patients with post-transfusion hepatitis, "positive" for Au antigen; (b) 8 sera from patients with post-transfusion hepatitis (drawn during the acute phase of their disease), "negative" for Au antigen; (c) 5 sera, which contained anti-Au antibodies, from patients with hemophilia; (d) 8 samples from patients with other forms of liver disease (alcoholic liver disease, 5; drug-induced hepatitis, 3); and (e) 50 control sera obtained from healthy adults and hospitalized patients with no evidence of liver disease as judged by history, physical examination, and laboratory screening procedures (serum bilirubin, transaminase, and alkaline phosphatase).
RESULTS
The technique for iodination of Au antigen described above results in incorporation of only about 1% of the 1251 used.
Systematic variation of the reaction conditions failed to increase the labeling efficiency. The limited incorporation of 125I on the Au antigen particles could be the result of a low tyrosine content or of low tyrosine reactivity (steric hindrance or hydrogen bonding). The precipitability of radioiodinated Au antigen prepared by zonal ultracentrifugation was consistently in the range of 65-75% at high concentrations of guinea pig anti-Au antibody. Incubation of [125] Au antigen with rabbit anti-human serum failed to reveal human serum protein contaminants after precipitation with goat serum that contained antibodies to rabbit IgG, which suggests that the protein that remained soluble may be Au antigen rendered nonimmunoreactive during purification or iodination. Although Au antigen prepared by column chromatography and CsCl ultracentrifugation was free of human serum protein components by immunoelectrophoresis and immunodiffusion, the maximal precipitability of radioiodinated preparations of this material with anti-Au antibody was 33%. The relatively low precipitability of this preparation seemed to be due to trace amounts of contaminating proteins that radiolabel more readily than Au antigen, since rabbit anti-human serum, in the presence of goat anti-rabbit IgG, precipitated up to 20% of the total radioactivity. The presence of radiolabel on protein other than Au antigen did not alter the specificity of the immunoassay (either with guinea pig or human antiAu antibody), as indicated by the fact that precipitation of [125I]Au was completely inhibited by Au-antigen-containing sera, whereas various dilutions of normal human serum did not inhibit. However, subsequent studies were conducted with radiolabeled Au antigen purified by zonal ultracentrifugation.
Immunized guinea pigs produced a high titer of anti-Au IgG antibodies. A standard titration curve of guinea pig anti-Au antiserum is compared to our highest titer human (hemophilia) anti-Au antiserum in Fig. 1 . The two antibody dilution curves are parallel, indicating that the same antigenic determinants are being measured. The linear portion of the titration curve for guinea pig antiserum fell between dilutions of 1:10,000 and 1:120,000; precipitation of radiolabeled Au antigen was still evident at an antibody dilution of 1: 200,000.
Addition of various amounts of normal human serum did not change the amount of 125J recovered in the p)recipitate.
Standard inhibition curves of several hepatitis sera containing Au antigen are shown in Fig. 2 . The curves are essentially parallel on a semilog plot. The limits of detection correspond to 0.010 to 0.002 microliter of the undiluted Au-'positive sera (dilutions of 1:10,000 to 1:40,000).
The effect of varying the length of the incubation period and the sequence in which the various reactants are added was evaluated. The greatest precipitation of the labeled Au antigen (70%) occurred with the longest incubation period (6 days at 4°C). However, 52% precipitation of [1251]Au antigen was obtained after 16 hr at 4°C. Incubation of a mixture of first and second antibody before the addition of 1251 essentially eliminated the precipitation of labeled antigen.
The relative sensitivity of the radioimmunoassay (completed in an 18-hr period) is compared to agar gel diffusion and quantitative complement fixation in Table 1 . Based on parallel studies with Au-antigen-"positive" sera, serially diluted either in normal human serum or standard diluents, the radioimmunoassay was 1200-3500 times more sensitive than agar gel diffusion and 160-240 times more sensitive than quantitative complement fixation in the detection of Au antigen. Relative sensitivities of agar gel diffusion (AGD), quantitative complement fixation (CF), and radioimmunoassay (RAI) in the detection of Au antigen. The values represent the maximal dilution at which Au antigen was still detectable. Each sample was tested at a volume of 0.05 ml. The radioimmunoassay curves for these sera are shown on Fig. 2. 
FIG. 3. Evaluation of 86 human sera for Au antigen or anti-
Au antibody by the double-antibody-radioimmunoassay technique. Five groups of sera (see text) were studied. All sera (0.05 ml) were evaluated at a dilution of 1:160. Each serum is represented in the figure by a single dot. The closed dots are sera that were "positive" for Au antigen or anti-Au antibody by agar gel diffusion and complement fixation. The amount of [126I]Au antigen added was 8000 cpm/tube for all groups, except for the five hemophilia sera that contain anti-Au antibody, to which 25,000 cpm/tube were added.
The results of the evaluation of 86 human sera are shown in Fig. 3 . In no instance was there overlap between Auantigen-"positive" or anti-Au-antibody-"positive" serum (as delineated by agar gel diffusion and complement fixation) with the control group. Differences in the mean values were statistically significant (P < 0.001) by Student's t test. Six of the 8 samples obtained from patients with a clinical diagnosis of post-transfusion hepatitis that were Au-antigen-"negative" exhibited an intermediate degree of inhibition between the 15 known Au-antigen-"positive" samples and control sera. One post-transfusion hepatitis sample was positive for anti-Au antibodies. Thus, of 23 serum samples obtained from patients in the acute stage of their disease, only one fell within the control range by radioimmunoassay. It should be emphasized that single serum samples (one from each patient) were used in this evaluation and that the sera were collected at various times during the acute phase of the disease. One of the 50 control sera appeared to fall clearly outside the rather tight grouping of the other 49 samples, in the range of the serum from the "Au-negative" hepatitis patients, raising the possibility that it contained a small amount of Au antigen not otherwise detectable. Review of this patient's chart revealed that he had received one unit of plasma in another hospital for a thirddegree burn 4 
DISCUSSION
This report describes the development of a sensitive and specific radioimmunoassay for Australia antigen. The assay utilizes 1251-labeled Au antigen, guinea pig anti-Au antibody (the first antibody), and rabbit serum with antibodies to guinea pig gamma globulin (second antibody). The radioimmunoassay for Au antigen differs from most other doubleantibody immunoassay systems in that it is necessary to incubate the Au antigen with the anti-Au antibody for at least 30 min before the second antibody is added. If the first and second antibodies are mixed before, or at the time of, addition of [1251]Au antigen, coprecipitation of labeled antigen is markedly inhibited. Evidently anti-Au antibody that has combined with second antibody is unable to bind Au antigen effectively. This observation is in contrast to what is observed with the insulin-anti-insulin immunoassay system (13) , where preformed first antibody-second antibody complexes can be used without reducing the sensitivity of the assay. In certain phage-anti-phage immune systems, the presence of second antibody greatly enhances the stability of the phage-anti-phage complexes (14) . The (4) . Presumably, antigenic determinants on the exterior surface of this particle would be readily accessible to anti-Au antibody, regardless of whether it was combined with rabbit anti-guinea pig antibody or not. Quite possibly, the antigen is partially buried within the matrix of the particle where sizable immune complexes have difficulty penetrating. Treatment of Au antigen particles with organic solvent gives results that support this explanation. After exposure to ether or genetron, particle size decreases to a diameter of about 160 Ai, but antigenic reactivity, as defined by quantitative complement fixation, increases (15) . However, difficulty in achieving equilibrium between the two particulate systems (Au antigen particles and preformed, insoluble immune complexes) can not be excluded.
In a radioimmunoassay for Au antigen, there is a choice between the use of human anti-Au antibody obtained from the serum of multiply-transfused patients and anti-Au antibody prepared in animals. With the reagents available to us, the sensitivity of the immunoassay with guinea pig antiAu as first antibody is about 20-fold greater than the sensitivity with the best human anti-Au antibody. This finding is not surprising, since the sensitivity of a radioimmunoassay depends in part on the affinity of the antibody for antigen. Immunization with moderate amounts of antigen in complete Freund's adjuvant favors the development of high-affinity antibody, especially if late bleedings are obtained (16) . It seems probable that with still later bleedings to prepare guinea pig antisera, the sensitivity of the assay may be further increased. Thus, the use of selected animal antisera may be a significant advantage of our assay procedure over the recently described immunoassay system developed independently by Walsh et al. (17) , in which human anti-Au antibody is used. Their system also differs in that chromatoelectrophoresis is used to separate free from antibody-bound antigen, and antigen and antibody are incubated together for 48-72 hr In the past several years, a number of methods have been described for the detection of Au antigen in serum. The first, agar gel diffusion, has been the least sensitive; it requires 24 hr or longer to become positive. Complement fixation by quantitative semi-micro (5) and micro titer methods (6) is considerably more sensitive, but is difficult to quantitate and poses problems in interpretation because of the occurrence of anticomplementary activity in certain human sera. More recently, various electrophoretic techniques have been reported (7, 8, 18) 
